MGIC Investment Corporation (MTG)
NYSEFinancialsInsurance - SpecialtySnapshot 2026-09-04
$31.01-1.46%
Close 2026-09-04 · 1-day change
NYSEFinancialsInsurance - SpecialtySnapshot 2026-09-04
QuarterlyIQ Insights · MTG
How strong the business is — where it ranks within its sector on capital efficiency and cash generation, and how well management has been executing.
How this business ranks within financials on a research-validated quality screen. As of 2026-09-04.
The screen ranks MTG against its sector on four durable signals: share dilution, return on capital, free-cash-flow yield, and FCF margin. Historically the highest-quality names tended toward better typical outcomes and fewer bad years over multi-year holds (strongest at three years, modest at one), and that pattern showed up even before the price moved. It characterizes business quality, not price direction.
Each leg is a sector-relative percentile (higher is better); 3 of 4 legs were available for this name. The composite is built from these four; the raw value follows each percentile for context.
A forward quality tilt, not a price prediction, and context for your own research rather than a recommendation. Not investment advice.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
A guidance track record builds as the company issues and delivers on guidance.
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
Continue returning capital through share repurchases and dividends to shareholders.
Stated as a priority in 3 of last 3 quarters. MGIC repurchased 6.8 to 7.2 million shares each quarter from 2025-Q4 to 2026-Q2, totaling over $550 million in repurchases, and paid consistent dividends of $0.15 per share. The board approved an additional $750 million repurchase authorization through 2028. The trajectory shows consistent delivery on capital return commitments.
“We repurchased 6.6 million shares for $176.6 million and paid a dividend of $0.15 per share.”
“We repurchased 7.2 million shares for $192.6 million and paid a dividend of $0.15 per share.”
“We repurchased 6.8 million shares for $189.1 million and paid a dividend of $0.15 per share.”
Sustain financial strength with robust capital, liquidity, and risk management.
Stated as a priority in 3 of last 3 quarters. PMIERs available assets remained stable between $5.6B and $5.8B, with excess capital between $2.5B and $2.9B, and holding company liquidity fluctuated from $709M to $1.07B. Management consistently emphasizes balance sheet strength, and financial metrics show stable capital and liquidity, indicating delivery on this priority.
“PMIERs available assets were $5.6 billion with $2.7 billion excess and holding company liquidity of $930 million.”
“PMIERs available assets were $5.8 billion with $2.9 billion excess and holding company liquidity of $709 million.”
“PMIERs available assets were $5.7 billion with $2.5 billion excess and holding company liquidity of $1.07 billion.”
Implement excess-of-loss and quota share reinsurance transactions to manage risk exposure.
Stated as a priority in 3 of last 3 quarters. MGIC executed a $250 million excess of loss reinsurance in 2025-Q4, a $324 million excess of loss agreement in 2026-Q1, and a $168 million excess-of-loss reinsurance in 2026-Q2, plus a 40% quota share reinsurance covering 2027 NIW. These transactions demonstrate consistent execution of reinsurance agreements as a risk management priority.
“We executed a traditional excess-of-loss reinsurance transaction providing up to $168 million coverage on eligible NIW in 2027.”
“Executed a $324 million excess of loss reinsurance agreement covering policies from 2022 to 2025.”
“Executed a 40% quota share reinsurance transaction covering eligible NIW in 2027 and a $250 million excess of loss reinsurance effective December 1, 2025.”
Increase new primary insurance written to expand business volume and market presence.
Stated as a priority in 3 of last 3 quarters. New primary insurance written increased from $15.9B in 2024-Q4 to $17.1B in 2025-Q4, then to $14.4B in 2026-Q1 and $17.8B in 2026-Q2, showing growth in new insurance written. Management emphasizes meeting customer needs and driving shareholder value, with the trajectory showing delivery on growth in new insurance written.
“New primary insurance written was $17.8 billion, up from $16.4 billion in 2025-Q2.”
“New primary insurance written was $14.4 billion, up from $10.2 billion in 2025-Q1.”
“New primary insurance written was $17.1 billion, up from $15.9 billion in 2024-Q4.”
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 1 of the last 3 quarter-over-quarter moves. Historically, Financials names rated neutral grew net income 55% of the time over the next year (vs 62% for the rest of the cohort, n=10246).
Over the trailing year it converted 0.95x of net income into operating cash flow. Historically, Financials names rated neutral grew net income 60% of the time over the next year (vs 57% for the rest of the cohort, n=9112).
Most sensitive to the broad stock market.
Not enough signal to read sensitivity to the US dollar, real (inflation-adjusted) rates, long-term interest rates, Fed net liquidity (low R² over the window).
4 material management or governance events in the past 24 months, led by executive changes. Historically, Financials names rated stable grew net income 56% of the time over the next year (vs 57% for the rest of the cohort, n=2725).
Not investment advice. As of 2026-09-04.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.